戻る Agenda
Session 2: Update from FDA
Session Chair(s)
Wayne Pines
President, Health Care
United States
This session will provide an update on recent guidances and enforcement actions taken by the FDA.
Learning Objective : At the conclusion of this session, participants should be able to:- Identify recent FDA enforcement actions
- Discuss trends that are taking place in enforcement
- Describe FDA enforcement priorities
- Discuss recent policy and guidance development for medical products
Speaker(s)
Speaker
Elizabeth Pepinsky, JD
FDA, United States
Health Science Policy Analyst
Speaker
Thomas W. Abrams, MBA, RPH
Former FDA, United States
Retired, Director, Office of Prescription Drug Promotion, OMP, CDER
Speaker
Lisa Stockbridge, PHD
FDA, United States
Branch Chief, Advertising and Promotional Labeling Branch, OCBQ, CBER
Speaker
Deborah Wolf, JD
FDA, United States
Regulatory Counsel, OPEQ , Regulatory Policy, CDRH